| P/E (FY) | — | Sales (TTM) | — |
| Earnings (TTM) | -$7.8M | ROE | −11.94% |
| Net Margin | — | ROIC | −19.15% |
| Debt / Equity | — | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | — |
| Market Cap | $36.6M | Trading Days | 434 |
| 52W High | 5.18 |
| 52W Low | 1.79 |
| % Off High | −56.56% |
| YTD | −34.97% | 1Y | −25.74% |
| Since incept. (ann.) | −18.41% |
| Ann. Volatility (1Y) | 71.75% | Ann. Volatility (3Y) | 71.79% |
| Sharpe (1Y) | 0.01 | Sharpe (3Y) | 0.11 |
| Max Drawdown (1Y) | −59.06% | Max Drawdown (3Y) | −60.00% |
| Beta (3Y, vs SPY) | −1.00 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| MIRA | MIRA PHARMACEUTICALS, INC. | $37.1M | — |
| PDSB | PDS Biotechnology Corp | $38.7M | — |
| HYPD | HYPERION DEFI, INC. | $38.8M | — |
| LITS | Lite Strategy, Inc. | $33.6M | — |
| NNVC | NANOVIRICIDES, INC. | $33.3M | — |
| LTRN | Lantern Pharma Inc. | $31.5M | — |
| SER | Serina Therapeutics, Inc. | $31.5M | — |
| FLNA | FILANA THERAPEUTICS, INC. | $43.0M | — |
| BCTX | BriaCell Therapeutics Corp. | $30.9M | — |
| RNXT | RenovoRx, Inc. | $43.5M | — |
| BHST | BIOHARVEST SCIENCES INC. | $46.0M |
| — |
| MCRB | Seres Therapeutics, Inc. | $46.5M | 7.6 |
